DK1150682T3 - Ubichinon Qn til behandling af migrænesmerter - Google Patents

Ubichinon Qn til behandling af migrænesmerter

Info

Publication number
DK1150682T3
DK1150682T3 DK00914075T DK00914075T DK1150682T3 DK 1150682 T3 DK1150682 T3 DK 1150682T3 DK 00914075 T DK00914075 T DK 00914075T DK 00914075 T DK00914075 T DK 00914075T DK 1150682 T3 DK1150682 T3 DK 1150682T3
Authority
DK
Denmark
Prior art keywords
treatment
ubichinone
migraine pain
migraine
pain
Prior art date
Application number
DK00914075T
Other languages
English (en)
Inventor
Franz Enzmann
Original Assignee
Mse Pharmazeutika Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7897295&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1150682(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mse Pharmazeutika Gmbh filed Critical Mse Pharmazeutika Gmbh
Application granted granted Critical
Publication of DK1150682T3 publication Critical patent/DK1150682T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK00914075T 1999-02-11 2000-02-09 Ubichinon Qn til behandling af migrænesmerter DK1150682T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19905879A DE19905879A1 (de) 1999-02-11 1999-02-11 Ubichinon Qn zur Behandlung von Schmerzen
PCT/EP2000/001011 WO2000047192A2 (de) 1999-02-11 2000-02-09 UBICHINON Qn ZUR BEHANDLUNG VON SCHMERZEN

Publications (1)

Publication Number Publication Date
DK1150682T3 true DK1150682T3 (da) 2005-12-19

Family

ID=7897295

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00914075T DK1150682T3 (da) 1999-02-11 2000-02-09 Ubichinon Qn til behandling af migrænesmerter

Country Status (7)

Country Link
EP (1) EP1150682B1 (da)
AT (1) ATE302009T1 (da)
CA (1) CA2362577A1 (da)
DE (2) DE19905879A1 (da)
DK (1) DK1150682T3 (da)
ES (1) ES2243243T3 (da)
WO (1) WO2000047192A2 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465517B1 (en) 2000-07-11 2002-10-15 N.V. Nutricia Composition for the treatment of migraine
AU2002309038B2 (en) * 2001-05-10 2007-05-17 Kaneka Corporation Compositions for transmucosal administration containing coenzyme Q as the active ingredient
EP1374883A1 (de) * 2002-06-21 2004-01-02 Roland. Dr. Lingg Nasenspray enthaltend ein Pflanzenextrakt zur Behandlung von Krankheiten wie Herpes Zoster, Blutergüssen, Mastitis und Kreislaufschwäche
ES2836184T3 (es) * 2006-05-02 2021-06-24 Univ Miami Formulaciones tópicas de co-enzima Q10 y tratamiento de heridas
MA52274A (fr) 2017-05-17 2021-02-24 Berg Llc Utilisation de formulations de coenzyme q10 dans le traitement et la prévention de l'épidermolyse bulleuse
WO2018218287A1 (en) * 2017-05-29 2018-12-06 Woodlinda Pty Ltd Treatment and/or prevention of neuropathic symptoms associated with diabetes mellitus type ii

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6277318A (ja) * 1985-10-01 1987-04-09 Eisai Co Ltd 熱傷治療剤
JPH01165522A (ja) * 1987-12-23 1989-06-29 M S C:Kk 鼻及びのどの疾患の治療剤
DE4327063A1 (de) * 1993-08-12 1995-02-16 Kirsten Dr Westesen Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
JP3612729B2 (ja) * 1994-04-12 2005-01-19 大正製薬株式会社 滋養強壮剤
GB9601398D0 (en) * 1996-01-24 1996-03-27 Piper Edwina M Composition
US6228891B1 (en) * 1997-02-12 2001-05-08 Mse Pharmazeutika Gmbh Use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
DE19905880A1 (de) * 1999-02-11 2000-08-17 Mse Pharmazeutika Gmbh Spray enthaltend Ubichinon Qn

Also Published As

Publication number Publication date
WO2000047192A2 (de) 2000-08-17
ES2243243T3 (es) 2005-12-01
ATE302009T1 (de) 2005-09-15
EP1150682A2 (de) 2001-11-07
CA2362577A1 (en) 2000-08-17
DE50010972D1 (de) 2005-09-22
EP1150682B1 (de) 2005-08-17
DE19905879A1 (de) 2000-08-17
WO2000047192A3 (de) 2001-04-12

Similar Documents

Publication Publication Date Title
TR200200204T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi.
DK1420801T3 (da) Anvendelse af fucaner til behandling af adhæsioner, arthritis og psoreasis
DK1196172T3 (da) (S,S)-reboxetin til behandling af kronisk smerte
ZA200500323B (en) Use of lkb kinase inhibitors for the treatment of pain.
DK2412368T3 (da) Sammensætning til behandling af ar
DK1562932T3 (da) 4 tetrazolyl-4-phenylpiperidinderivater til behandling af smerter
DK1047428T3 (da) Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
DK1758860T3 (da) Mættede og umættede 3-pyridylbenzocykloalkylmethylaminer til behandling af smerter, depressioner og angsttilstande
DK1223927T3 (da) Anvendelse af retigabin til behandling af neuropatiske smerter
DK1955700T3 (da) Terapeutisk behandling af androgenreceptor-betingede lidelser
DK1446012T3 (da) Bakteriolytisk kombinationsterapi til behandling af tumorer
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
AU3831301A (en) Method for treating ocular pain
DK1282616T3 (da) Hydroxyphenylpiperidin-4-ylidenmethylbenzamidderivater til behandling af smerter
NO20055563L (no) Midler for behandlingen av lavere abdominale lidelser
DK1001761T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsunderskudslidelser
DK1383742T3 (da) Syntese og fremgangsmåder til anvendelse af tetrahydroindolonanaloge og derivater
FI20000635A0 (fi) COMT-inhibiittoreiden käyttö analgeettina
DK1150682T3 (da) Ubichinon Qn til behandling af migrænesmerter
TR200200278T2 (tr) Kalsilitik bileşimler
DK1530462T3 (da) 1-phenyl-2-dimethylaminomethylcyclohexanforbindelser til behandling af depressionssymtomer. smerte og inkontinens
DK1223930T3 (da) Behandling af dyskinesi
NO20005548D0 (no) Mykobakterieinhibitorer
DK1455770T3 (da) Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser
SE9800139D0 (sv) New use